Latest News

Changes in the gut microbiome can ultimately lead to cardiovascular disease. Yet some of the alterations appear to normalize in chronic conditions, a team led by ECRC researcher Sofia Forslund reports in Nature Medicine. This finding may have clinical implications.

Twelve European experts have been commissioned by the European Association of Preventive Cardiology (EAPC) to analyse the scientific status and clinical significance of psychosocial issues for heart failure for the first time. They have published their findings in a position...

A new study by the German Center for Cardiovascular Research (DZHK) examines whether patients with a leaky (insufficient) tricuspid valve benefit from catheter-assisted heart valve repair. Scientists at LMU Klinikum München lead the study.

Cardiovascular diseases can be treated better today than ever before. At the same time, they remain among the leading causes of death. Understanding cardiovascular disease in detail is essential for further progress. Researchers from Hamburg, Lübeck and Munich have used a...

The German Heart Foundation provides information on the risks of myocarditis from Covid-19 and mRNA vaccination. One expert says: "The health risk from a Covid-19 infection - in every age group - is much higher than the risk of myocarditis from mRNA vaccination."

The interplay of genetics and epigenetics is a long-sought riddle in the development of diseases. Researchers from Helmholtz Munich and the Imperial College London discovered novel interactions. Their findings improve our knowledge about environmentally triggered diseases and may...

A research team led by Stefan Engelhardt, Professor of Pharmacology and Toxicology at the Technical University of Munich (TUM) and Principal Investigator at the DZHK, has developed a new RNA drug that can prevent inflammatory lung damage. The German Federal Ministry of Education...

Musclin, a hormone-like messenger substance of the skeletal muscle, protects against the pathological overload of the heart. For patients with chronic heart failure, the discovery could open up advances in therapy.

Even mild disease courses with COVID-19 impair the heart, lungs and kidneys. Scientists from the Hamburg University Medical Center Hamburg-Eppendorf (UKE) proved this. In addition, with mild to moderate infections, there are frequent signs of thrombosis in the leg veins. The...

The German Center for Cardiovascular Research (DZHK) is funding several special evaluations of the German Aortic Valve Registry (GARY). The results will ensure that different groups of patients with heart valve disease requiring surgery receive the optimal therapy: either...